Abstract
The clinical research and the metabolic and therapeutic concerns related to the administration of fluoride for osteoporotic lesions are reviewed. Two or three daily administrations of 22.4 mg of sodium fluoride (NaF) have been shown to stimulate osteoblastic activity. When accompanied by supplemental calcium (Ca) new normal bone is deposited leading to an increase in total bone mass. The Ca should be given daily in 600 to 1,000 mg quantity at times separate from the fluoride ingestion to avoid formation of insoluble calcium fluoride. Vitamin D may also be prescribed to aid Ca absorption. The precise mechanism of action is not yet known. Promising clinical results have been obtained with a variety of osteoporotic conditions including “otosclerosis.”
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
